樂觀
$2.52
情境價格
$1.310
-0.039 (-2.96%)收盤時
Akso Health Group is a holding company mainly engaged in marketing promotion services and sales of medical devices. The marketing promotion services business is principally engaged in the provision of marketing promotion services to car insurance broker industry. The sales of medical devices business is mainly engaged in the sale of medical devices such as defibrillators and anesthesia laryngoscope. The Company also provides radiotherapy (RT), personalized consultation, conventional treatment planning, and other related services for a wide variety of cancer therapy treatments, as well as online healthcare services, including health consultancy services and online sales of medicines and health products through the online health product marketplace.
Akso Health Group (AHG) is a good buy right now due to its recent price surge of 9.65% yesterday and an impressive 48.95% increase over the last 20 days. The current RSI of 78.524 indicates strong momentum, although it is approaching overbought territory. The stock's projected final change of +161.29% based on historical patterns suggests substantial upside potential. However, the main risk is its negative P/E ratio of -6.036, indicating potential underlying issues with profitability.
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

Akso Health Launches Brain-Computer Interface R&D Program

Akso Health Initiates Brain-Computer Interface R&D Program

U.S. Stocks Rise as NIO Reports Strong Earnings

U.S. Stocks Mixed in Morning Trading

Ingram Micro Reports Strong Quarterly Earnings, Shares Surge
Akso Health Group is a holding company mainly engaged in marketing promotion services and sales of medical devices. The marketing promotion services business is principally engaged in the provision of marketing promotion services to car insurance broker industry. The sales of medical devices business is mainly engaged in the sale of medical devices such as defibrillators and anesthesia laryngoscope. The Company also provides radiotherapy (RT), personalized consultation, conventional treatment planning, and other related services for a wide variety of cancer therapy treatments, as well as online healthcare services, including health consultancy services and online sales of medicines and health products through the online health product marketplace. It operates in the Technology sector (BUSINESS SERVICES, NOT ELSEWHERE CLASSIFIED industry).
Akso Health Group (AHG) is a good buy right now due to its recent price surge of 9.65% yesterday and an impressive 48.95% increase over the last 20 days. The current RSI of 78.524 indicates strong momentum, although it is approaching overbought territory. The stock's projected final change of +161.29% based on historical patterns suggests substantial upside potential. However, the main risk is its negative P/E ratio of -6.036, indicating potential underlying issues with profitability.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。